Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A2 | P23975 | 13/20 | 0.61 |
| ▸ | SLC6A4 | P31645 | 13/20 | 0.61 |
| ▸ | SLC6A3 | Q01959 | 10/20 | 0.61 |
| ▸ | HTR1A | P08908 | 10/20 | 0.61 |
| ▸ | HTR6 | P50406 | 6/20 | 0.48 |
| ▸ | ALOX5AP | P20292 | 1/20 | 0.39 |
| ▸ | FEN1 | P39748 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25971055 | 0.85 | SLC6A2 (0.70) | SLC6A2SLC6A4SLC6A3HTR1AHTR6 | |
| SCHEMBL24574655 | 0.83 | HTR6 (0.56) | SLC6A2SLC6A4SLC6A3HTR1AHTR6 | |
| SCHEMBL24919613 | 0.80 | SLC6A2 (0.50) | SLC6A2SLC6A4SLC6A3HTR1AHTR6 | |
| SCHEMBL20280066 | 0.78 | GLP1R (0.52) | HTR1A | |
| SCHEMBL29518203 | 0.78 | GLP1R (0.52) | HTR1A | |
| SCHEMBL30899099 | 0.78 | SLC6A2 (0.50) | SLC6A2SLC6A4SLC6A3HTR1AHTR6 | |
| Hydrochloric Acid SCHEMBL28781153 | 0.78 | GLP1R (0.51) | HTR1A | |
| Hydrochloric Acid SCHEMBL29664360 | 0.78 | GLP1R (0.51) | HTR1A | |
| SCHEMBL3321425 | 0.77 | SLC6A2 (0.70) | SLC6A2SLC6A4SLC6A3HTR1AHTR6 | |
| SCHEMBL31140532 | 0.76 | PRMT5 (0.46) | SLC6A2SLC6A4SLC6A3HTR1AHTR6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4688144-A1 | COMPOUNDS AS GLP-1R AGONISTS | Terns Pharmaceuticals, Inc. (US) | 2026-02-11 | — | — | EP | disclosed |
| WO-2024206878-A1 | COMPOUNDS AS GLP-1R AGONISTS | TERNS PHARMACEUTICALS, INC. (US) | 2024-10-03 | — | — | WO | disclosed |